Cargando…
Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853251/ https://www.ncbi.nlm.nih.gov/pubmed/32811798 http://dx.doi.org/10.4103/ijmr.IJMR_3077_20 |
| _version_ | 1783645921937981440 |
|---|---|
| author | Pareek, Anil Bhandari, Sudhir Mehta, Ravi Tejraj |
| author_facet | Pareek, Anil Bhandari, Sudhir Mehta, Ravi Tejraj |
| author_sort | Pareek, Anil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7853251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78532512021-02-04 Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen Pareek, Anil Bhandari, Sudhir Mehta, Ravi Tejraj Indian J Med Res Correspondence Wolters Kluwer - Medknow 2020 /pmc/articles/PMC7853251/ /pubmed/32811798 http://dx.doi.org/10.4103/ijmr.IJMR_3077_20 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Correspondence Pareek, Anil Bhandari, Sudhir Mehta, Ravi Tejraj Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title | Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title_full | Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title_fullStr | Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title_full_unstemmed | Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title_short | Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen |
| title_sort | hydroxychloroquine for prophylaxis in covid-19: need to revisit dosing regimen |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853251/ https://www.ncbi.nlm.nih.gov/pubmed/32811798 http://dx.doi.org/10.4103/ijmr.IJMR_3077_20 |
| work_keys_str_mv | AT pareekanil hydroxychloroquineforprophylaxisincovid19needtorevisitdosingregimen AT bhandarisudhir hydroxychloroquineforprophylaxisincovid19needtorevisitdosingregimen AT mehtaravitejraj hydroxychloroquineforprophylaxisincovid19needtorevisitdosingregimen |